Increased Prevalence of Glycoprotein IIb/IIIa Leu 33 Pro Polymorphism in End Stage Renal Disease Patients on Hemodialysis

Increased Prevalence of Glycoprotein IIb/IIIa Leu 33 Pro Polymorphism in End Stage Renal Disease Patients on Hemodialysis

Traditional atherosclerosis risk factors cannot elucidate the increased prevalence of cardiovascular events in end stage renal disease (ESRD) patients on hemodialysis. A previous study has indicated a strong association of the PIA1/A2 polymorphism with myocardial infarction, diabetes and renal allog...

Full description

Bibliographic Details
Main Authors: Al-Ali, Amein, Al-Muhanna, Fahad, Al-Mueilo, Samir, Larbi, Emmanuel, Al-Sultan, Ali, Rubaish, Abdullah, Al-Ateeq, Suad, Al-Zaharani, Alhusain
Format: Online
Language:English
Published: Master Publishing Group 2008
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3614702/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3614702/

Similar Items